BamSEC and AlphaSense Join Forces
Learn More

Outlook Therapeutics Inc. – Indentures

NASDAQ: OTLK    
Share price (9/23/26): $0.66    
Market cap (9/23/26): $161 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 16 pages Form of Common Stock Purchase Warrant Outlook Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 2 pages Gms Ventures & Investments Intertrust Corporate Services(cayman)ltd, 190 Elgin Avenue, George Town Grand Cayman, E9, Kyi-9007 962 6 582 7999 May 28, 2026 Re: Amendment to Existing Warrants
12/34/56
EX-4.2
from 8-K 14 pages Form of Placement Agent Common Stock Purchase Warrant Outlook Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 14 pages Form of Common Stock Purchase Warrant Outlook Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 14 pages Form of Placement Agent Common Stock Purchase Warrant Outlook Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 14 pages Form of Common Stock Purchase Warrant Outlook Therapeutics, Inc
12/34/56
EX-4.1
from 10-K 3 pages Description of Registrant’s Securities
12/34/56
EX-4.1
from 8-K 17 pages Form of Common Stock Purchase Warrant Outlook Therapeutics, Inc
12/34/56
EX-4.4
from 8-K 18 pages Form of Common Stock Purchase Warrant Outlook Therapeutics, Inc
12/34/56
EX-4.3
from 8-K 18 pages Form of Common Stock Purchase Warrant Outlook Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 18 pages Form of Common Stock Purchase Warrant Outlook Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 18 pages Form of Common Stock Purchase Warrant Outlook Therapeutics, Inc
12/34/56
EX-4.1
from 10-K 3 pages Description of Registrant’s Securities
12/34/56
EX-4.6
from S-3 16 pages Outlook Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Outlook Therapeutics, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.5
from S-3 16 pages Outlook Therapeutics, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Outlook Therapeutics, Inc. Form of Preferred Stock Warrant Agreement
12/34/56
EX-4.4
from S-3 16 pages Outlook Therapeutics, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Outlook Therapeutics, Inc. Form of Common Stock Warrant Agreement
12/34/56
EX-4.2
from S-3 40 pages Outlook Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], 2024 Debt Securities 1
12/34/56
EX-4.2
from 8-K 18 pages Form of Common Stock Purchase Warrant Outlook Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 18 pages Form of Common Stock Purchase Warrant Outlook Therapeutics, Inc
12/34/56
EX-4.1
from 10-K 4 pages Description of Registrant’s Securities
12/34/56